and consequences involving amyloid b-peptide-associated free
radical oxidative stress. Free Radic. Biol. Med. 32, 1050–1060.
Butterfield D. A. and Stadtman E. R. (1997) Protein oxidation processes
in aging brain. Adv. Cell Aging Gerontol. 2, 161–191.
Calabrese V., Boyd-Kimball D., Scapagnini G. and Butterfield D. A.
(2004) Nitric oxide and cellular stress response in brain aging and
neurodegenerative disorders: the role of vitagenes. In Vivo 18, 245–
267.
Candolfi M., Jaita G., Zaldivar V., Zarate S., Pisera D. and Seilicovich A.
(2004) Tumor necrosis factor-alpha-induced nitric oxide restrains
the apoptotic response of anterior pituitary cells. Neuroendocrinology 80, 83–91.
Castegna A., Thongboonkerd V., Klein J. B., Lynn B., Markesbery W. R.
and Butterfield D. A. (2003) Proteomic identification of nitrated
proteins in Alzheimer's disease brain. J. Neurochem. 85, 1394–
1401.
Chaiswing L., Cole M. P., St Clair D. K., Ittarat W., Szweda L. I. and
Oberley T. D. (2004) Oxidative damage precedes nitrative damage
in adriamycin-induced cardiac mitochondrial injury. Toxicol.
Pathol. 32, 536–547.
Choi J. S., Chung H. Y., Kang S. S., Jung M. J., Kim J. W., No J. K. and
Jung H. A. (2002) The structure-activity relationship of flavonoids
as scavengers of peroxynitrite. Phytother. Res. 16, 232–235.
Cooper C. E. and Brown G. C. (1994) The interactions between nitric
oxide and brain nerve terminals as studied by electron paramagnetic resonance. FEBS Lett. 356, 295–298.
Cooper C. E., Davies N. A., Psychoulis M., Canevari L., Bates T. E.,
Dobbie M. S., Casley C. S. and Sharpe M. A. (2003) Nitric oxide
and peroxynitrite cause irreversible increases in the K(m) for
oxygen of mitochondrial cytochrome oxidase: in vitro and in vivo
studies. Biochem. Biophys. Acta 17, 27–34.
Espey M. G., Miranda K. M., Pluta R. M. and Wink D. A. (2000)
Nitrosative capacity of macrophages is dependent on nitric-oxide
synthase induction signals. J. Biol. Chem. 275, 11 341–11 347.
Gonzalez-Zulueta M., Ensz L. M., Mukhina G., Lebovitz R. M., Zwacka
R. M., Engelhardt J. F., Oberley L. W., Dawson V. L. and Dawson
T. M. (1998) Manganese superoxide dismutase protects nNOS
neurons from NMDA and nitric oxide-mediated neurotoxicity.
J. Neurosci. 18, 2040–2055.
Gutierrez E. G., Banks W. A. and Kastin A. J. (1993) Murine tumor
necrosis factor alpha is transported from blood to brain in the
mouse. J. Neuroimmunol. 47, 169–176.
Gyorffy B., Serra V., Jurchott K., Abdul-Ghani R., Garber M., Stein U.,
Petersen I., Lage H., Dietel M. and Schafer R. (2005) Prediction of
doxorubicin sensitivity in breast tumors based on gene expression
profiles of drug-resistant cell lines correlates with patient survival.
Oncogene 24, 7542–7551.
Halliwell B. and Gutteridge J. M. C. (1999) Free Radicals In Biology
and Medicine. Third Edition, Oxford University Press, UK.
Huang T. T., Carlson E. J., Raineri I., Gillespie A. M., Kozy H. and
Epstein C. J. (1999) The use of transgenic and mutant mice to
study oxygen free radical metabolism. Ann. N Y Acad. Sci. 893,
95–112.
Joshi G., Sultana R., Tangpong J., Cole M. P., St. Clair D. K., Vore M.,
Estus S. and Butterfield D. A. (2005) Free radical mediated oxidative stress and toxic side effects in brain induced by the anti
cancer drug adriamycin: insight into chemobrain. Free Rad. Res.
39, 1147–1154.
Kalivendi S. V., Kotamraju S., Zhao H., Joseph J. and Kalyanaraman B.
(2001) Doxorubicin-induced apoptosis is associated with increased
transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J. Biol. Chem. 276, 47 266–
47 276.
